MedTrace Logo

A Study to Examine the Human Papillomavirus Types Exposure in Women From Southern Africa and Brasil

NCT00840905 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 487

Last updated 2012-11-07

No results posted yet for this study

Summary

This is a study to determine what Human Papillomavirus HIV seropositive women in Botswana, South Africa and Brasil have been exposed to during their life. The Human Papillomavirus causes cervical cancer. Different types are more likely to lead to cancer than other types. A vaccine has been made to fight infection against HPV 16 and 18 which has been shown to cause cervical cancer in America and Europe. What HPV type cause cancer in other countries is not as well studied.

Hypothesis HPV serology will demonstrate that exposure to each HPV type in Gardisil (6,11,16,18) will be \<50% in HIV seropositive women in resource limited countries.

Conditions

  • HIV
  • HIV Infections

Sponsors & Collaborators

Principal Investigators

  • Cynthia S Firnhaber, MD · Clinical HIV Research Unit University of Witwatersrand

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-02-28
Primary Completion
2010-03-31
Completion
2010-12-31

Countries

  • Botswana
  • Brazil
  • South Africa

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00840905 on ClinicalTrials.gov